日本口腔外科学会雑誌
Online ISSN : 2186-1579
Print ISSN : 0021-5163
ISSN-L : 0021-5163
Carcinoma in pleomorphic adenoma
腫瘍マーカーに関する免疫組織化学的研究
立本 行宏熊佐 俊介岩井 克正折戸 忠志高井 良招森 昌彦相楽 貞文奥富 直安岡 忠立松 憲親岡 伸光
著者情報
ジャーナル フリー

1988 年 34 巻 5 号 p. 814-825

詳細
抄録
Carcinoma in pleomorphic adenoma (Ca in PA) is a rare lesion which is composed of a malignant tumor or is transformed from a benign pleomorphic adenoma. We describe immunohistochemical investigations of tumor markers in 5 cases of carcinoma in pleomorphic adenoma; keratin (polyclonal; TK: 41-65 kDa, monoclonal: KL1: 55-57 kDa; PKK1: 40, 45 and 52.5 kDa), vimentin, desmin, involucrin (Inv), S-100 protein, lysozyme (LZ), lactoferrin (LF), α1-antitrypsin (α1-At), α1-antichymotrysin (α1-Ach), carcinoembryonic antigen (polyclonal; CEA (P), NCA-absorbed polyclonal; CEA (N), monoclonal; CEA (M)), and epithelial membrane antigen (EMA).
1) Keratin which is an intermediate sized filament protein and an epithelial marker, is not a specific marker for this tumor. It showed both malignant and benign tumor cells, and did not discriminate the two lesions. Inv is lackeing in the tumor, but is detected in squamous metaplasia or keratinizing of the changed area.
2) S-100 proteins showed great variations for staining in tumor cells. Normal myoepithelial cells do not always show positive reactions.
3) LZ, LF, α1-At, and α1-Ach showed mostly negative in the cells of Ca in PA. They were associated with bacteriostatic mechanisms as a focal defence mechanism.
4) Polyclonal CEA reaction is not specific, and the reaction product appeared in both carcinoma and pleomorphic adenoma. True CEA reaction between cancer and pleomorhic adenoma tissues was unexpected.
5) EMA is a more useful and suspected tumor markers in correlation with histologic malignancy, grading and/or possibility.
著者関連情報
© 社団法人日本口腔外科学会
前の記事 次の記事
feedback
Top